Gentafix® (1, 3, 3MV)
Bone Cement, Antibiotic. 510(k) K242216, from Teknimed Sas (L'Union, FR). Product code MBB, class 2.
As of Nov 18, 2026, K242216 is an FDA 510(k) held by Teknimed Sas, substantially equivalent on Dec 18, 2024 after 142 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Dec 18, 2024
- Review time: 142 days
- Recalls: 0
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFGENTAFIX is indicated for use as bone cement in arthroplasty procedures of the hip, knee, and other joints to fix plastic and metal prosthetic parts to living bone when reconstruction is necessary because of revision of previous arthroplasty procedures due to joint infection.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Cemex Genta, Genta System And Genta System FastK092773 · Tecres S.P.A. · Nov 24, 2009
Other MBB Clearances
The newest 510(k)s for the same product code; their median review was 184 days; see every MBB device- SpaceFix Shoulder SpacerK252443 · G21, S.R.L. · Sep 15, 2025
- Hip Spacer Molds; Knee Spacer Molds; Shoulder Spacer MoldsK240856 · Osartis GmbH · Nov 20, 2024
- StageOne™ Select Hip Cement Spacer MoldsK222760 · Biomet, Inc. · Dec 28, 2022
- StageOne™ Shoulder Cement Spacer MoldsK221968 · Biomet, Inc. · Sep 15, 2022
- StageOne Knee Cement Spacer MoldsK213287 · Biomet, Inc. · Sep 2, 2022
- SpaceFlex ShoulderK202338 · G21, S.R.L. · Feb 17, 2021
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jul 29, 2024
- Review panel
- Orthopedic
- Regulation
- 21 CFR 888.3027
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files